CYPHERPUNK TECHNOLOGIES INC. short interest in 2025
In 2025, CYPHERPUNK TECHNOLOGIES INC.'s disclosed short interest ran from 6.41% of shares outstanding on 15 Jan 2025 to 8.92% on 31 Dec 2025, a change of +2.51 percentage points. The year's high was 9.24% on 31 Mar 2025 and its low 2.27% on 30 Sep 2025, averaging 5.43% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.95 days on 15 Jan 2025. Full history: CYPHERPUNK TECHNOLOGIES INC..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 6.41% (15 Jan 2025)
- End of year
- 8.92% (31 Dec 2025)
- Change
- +2.51 pp
- High
- 9.24% (31 Mar 2025)
- Low
- 2.27% (30 Sep 2025)
- Average
- 5.43%
- Highest days to cover
- 7.95 (15 Jan 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 6.41% | 7.95 | |
| 31 Jan 2025 | 8.37% | 1.42 | |
| 14 Feb 2025 | 5.55% | 2.44 | |
| 28 Feb 2025 | 4.94% | 5.50 | |
| 14 Mar 2025 | 4.01% | 5.94 | |
| 31 Mar 2025 | 9.24% | 1.00 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 8.39% | 5.03 | |
| 30 Apr 2025 | 5.35% | 4.90 | |
| 15 May 2025 | 4.58% | 6.24 | 10-Q filed, results (8-K) |
| 30 May 2025 | 3.73% | 6.08 | |
| 13 Jun 2025 | 3.86% | 3.94 | |
| 30 Jun 2025 | 6.92% | 1.00 | |
| 15 Jul 2025 | 4.97% | 5.04 | |
| 31 Jul 2025 | 3.70% | 5.04 | |
| 15 Aug 2025 | 4.18% | 1.00 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 3.96% | 1.55 | |
| 15 Sep 2025 | 3.42% | 2.44 | |
| 30 Sep 2025 | 2.27% | 1.00 | |
| 15 Dec 2025 | 5.79% | 1.00 | 10-Q filed, results (8-K) |
| 31 Dec 2025 | 8.92% | 1.00 |
See also: CYPHERPUNK TECHNOLOGIES INC.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.